Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Teratoma epidemiology and demographics

Introduction

Overview

Overview

Epidemiology and Demographics

Epidemiology and Demographics

Incidence

  • The incidence of mature teratoma is approximately 1.2-14.2 cases per 100,000 individuals worldwide.[1]

Prevalence

  • The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
  • The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

Case-fatality rate/Mortality rate

  • In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
  • The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Age

  • Immature is mostly seen in younger patients and postpubertal males.[2][3]
  • Mature teratoma commonly affects aldolescent, but it occurs in all age groups.[2]

Race

  • There is no racial predilection to [disease name].
  • [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].

Gender

  • [Disease name] affects men and women equally.
  • [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.

Region

  • The majority of [disease name] cases are reported in [geographical region].
  • [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

Developed Countries

Developing Countries

References

References

  1. ↑ Westhoff C, Pike M, Vessey M (1988). “Benign ovarian teratomas: a population-based case-control study”. Br J Cancer. 58 (1): 93–8. doi:10.1038/bjc.1988.171. PMC 2246492. PMID 3166898.
  2. ↑ 2.0 2.1 Kao CS, Bangs CD, Aldrete G, Cherry AM, Ulbright TM (2018). “A Clinicopathologic and Molecular Analysis of 34 Mediastinal Germ Cell Tumors Suggesting Different Modes of Teratoma Development”. Am J Surg Pathol. 42 (12): 1662–1673. doi:10.1097/PAS.0000000000001164. PMID 30256256.
  3. ↑ Outwater, Eric K.; Siegelman, Evan S.; Hunt, Jennifer L. (2001). “Ovarian Teratomas: Tumor Types and Imaging Characteristics”. RadioGraphics. 21 (2): 475–490. doi:10.1148/radiographics.21.2.g01mr09475. ISSN 0271-5333.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Gertrude Djouka, M.D.[2]